Canton Strategic Holdings, Inc.
Key Metrics
Market Snapshot
About
Canton Strategic Holdings, Inc. (CNTN) is a US-based firm headquartered in Red Bank, New Jersey, known for operating at the intersection of digital assets and biotechnology.
The company operates through two distinct segments. The first is a Digital Asset Treasury segment, which manages blockchain and cryptocurrency-related activities. This includes operating validator nodes for network participation, making strategic investments in digital assets, and managing a treasury that involves token-related activities such as lending. The company also supports a related foundation and engages in ecosystem development within this space.
Its second segment is Clinical Stage Bio-technology, focused on researching and developing novel pharmaceutical treatments. Its pipeline includes GV104, a buccal film formulation intended for treating respiratory depression and providing protection against synthetic opioid exposure, with potential applications for military personnel and first responders. Another candidate, GV023, is an oral monoclonal antibody being studied as a treatment for conditions currently addressed by intravenous therapies. The company was originally known as Tharimmune, Inc. before changing its name in 2026.